Double KL; Gerlach M; Youdim MB; Riederer P, 2000, 'Impaired iron homeostasis in Parkinson`s disease', in Advances in Research on Neurodegeneration, Springer Publishing Company, Vienna, pp. 37 - 58

Harper C; Sheedy D; Halliday GM; Double KL; Dodd P; Lowehl JM; Kril J, 1998, 'Neuropathological studies: the relationship between alcohol and ageing', in NIAAA Research monograph 33: Alcohol Problems and Aging, edn. Original, US Department of Health and Human Services, Bethesda, MD USA, pp. 117 - 134

Purves-Tyson TD; Owens SJ; Rothmond DA; Halliday GM; Double KL; Stevens J; McCrossin T; Shannon Weickert C, 2017, 'Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain', Translational Psychiatry, vol. 7, http://dx.doi.org/10.1038/tp.2016.257

Tan B; Double KL; Burne J; Diong J, 2016, 'Tension-referenced measures of gastrocnemius slack length and stiffness in Parkinson's disease', Movement Disorders, vol. 31, pp. 1914 - 1918, http://dx.doi.org/10.1002/mds.26530

Weissleder C; Fung SJ; Wong MW; Barry G; Double KL; Halliday GM; Webster MJ; Weickert CS, 2016, 'Decline in proliferation and immature neuron markers in the human subependymal zone during aging: Relationship to EGF- and FGF-related transcripts', Frontiers in Aging Neuroscience, vol. 8, http://dx.doi.org/10.3389/fnagi.2016.00274

Davies KM; Mercer JFB; Chen N; Double KL, 2016, 'Copper dyshomoeostasis in Parkinson's disease: Implications for pathogenesis and indications for novel therapeutics', Clinical Science, vol. 130, pp. 565 - 574, http://dx.doi.org/10.1042/CS20150153

Davies KM; Hare DJ; Bohic S; James SA; Billings JL; Finkelstein DI; Doble PA; Double KL, 2015, 'Comparative Study of Metal Quantification in Neurological Tissue Using Laser Ablation-Inductively Coupled Plasma-Mass Spectrometry Imaging and X-ray Fluorescence Microscopy', Analytical Chemistry, vol. 87, pp. 6639 - 6645, http://dx.doi.org/10.1021/acs.analchem.5b01454

Todd G; Haberfield M; Faulkner PL; Hayes M; Wilcox RA; Rae C; Bulathsinhala T; Grunstein RR; Yee BJ; Double KL, 2015, 'Upper limb function is normal in patients with restless legs syndrome (Willis-Ekbom Disease)', Clinical Neurophysiology, vol. 126, pp. 736 - 742, http://dx.doi.org/10.1016/j.clinph.2014.07.010

Purves-Tyson TD; Boerrigter D; Allen K; Zavitsanou K; Karl T; Djunaidi V; Double KL; Desai R; Handelsman DJ; Weickert CS, 2015, 'Testosterone attenuates and the selective estrogen receptor modulator, raloxifene, potentiates amphetamine-induced locomotion in male rats', Hormones and Behavior, vol. 70, pp. 73 - 84, http://dx.doi.org/10.1016/j.yhbeh.2015.02.005

Schroeder RL; Double KL; Gerber JP, 2015, 'Using Sepia melanin as a PD model to describe the binding characteristics of neuromelanin - A critical review', Journal of Chemical Neuroanatomy, vol. 64-65, pp. 20 - 32, http://dx.doi.org/10.1016/j.jchemneu.2015.02.001

Todd G; Haberfield M; Faulkner PL; Rae C; Hayes M; Wilcox RA; Taylor JL; Gandevia SC; Godau J; Berg D; Piguet O; Double KL, 2014, 'Hand function is impaired in healthy older adults at risk of Parkinson’s disease', Journal of Neural Transmission, vol. 121, pp. 1377 - 1386, http://dx.doi.org/10.1007/s00702-014-1218-y

Davies KM; Bohic S; Carmona A; Ortega R; Cottam V; Hare DJ; Finberg JPM; Reyes S; Halliday GM; Mercer JFB; Double KL, 2014, 'Copper pathology in vulnerable brain regions in Parkinson's disease', Neurobiology of Aging, vol. 35, pp. 858 - 866, http://dx.doi.org/10.1016/j.neurobiolaging.2013.09.034

Purves-Tyson TD; Owens SJ; Double KL; Desai R; Handelsman DJ; Weickert CS, 2014, 'Testosterone induces molecular changes in dopamine signaling pathway molecules in the adolescent male rat nigrostriatal pathway', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0091151

Reyes S; Cottam V; Kirik D; Double KL; Halliday GM, 2013, 'Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra', Movement Disorders, vol. 28, pp. 1351 - 1359, http://dx.doi.org/10.1002/mds.25493

Dang TNT; Dobson-Stone C; Glaros EN; Kim WS; Hallupp M; Bartley L; Piguet O; Hodges JR; Halliday GM; Double KL; Schofield PR; Crouch PJ; Kwok JBJ, 2013, 'Endogenous progesterone levels and frontotemporal dementia: Modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model', DMM Disease Models and Mechanisms, vol. 6, pp. 1198 - 1204, http://dx.doi.org/10.1242/dmm.011460

Davies KM; Hare DJ; Cottam V; Chen N; Hilgers L; Halliday GM; Mercer JFB; Double KL, 2013, 'Localization of copper and copper transporters in the human brain', Metallomics, vol. 5, pp. 43 - 51, http://dx.doi.org/10.1039/c2mt20151h

Reyes S; Fu Y; Double KL; Cottam V; Thomp LH; Kirik D; Paxinos G; Watson C; Cooper HM; Halliday GM, 2013, 'Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease', Neurobiology of Aging, vol. 34, pp. 873 - 886, http://dx.doi.org/10.1016/j.neurobiolaging.2012.07.019

Double KL, 2012, 'Neuronal vulnerability in Parkinson's disease', Parkinsonism and Related Disorders, vol. 18, http://dx.doi.org/10.1016/s1353-8020(11)70018-9

Double KL, 2012, 'Neuronal vulnerability in Parkinson's disease', Parkinsonism and Related Disorders, vol. 18, pp. 52 - 54

Chan SW; Dunlop RA; Rowe A; Double KL; Rodgers KJ, 2012, 'L-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease, inducing toxicity in human neuroblastoma cells in vitro', Experimental Neurology, vol. 238, pp. 29 - 37, http://dx.doi.org/10.1016/j.expneurol.2011.09.029

Reyes S; Fu Y; Double KL; Thompson L; Kirik D; Paxinos G; Halliday GM, 2012, 'GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area', Journal of Comparative Neurology, vol. 520, pp. 2591 - 2607, http://dx.doi.org/10.1002/cne.23051

Purves-Tyson TD; Handelsman D; Double KL; Bustamante S; owens SJ; Shannon Weickert C, 2012, 'Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra', BMC Neuroscience, vol. 13, pp. 95, http://dx.doi.org/10.1186/1471-2202-13-95

Todd G; Taylor JL; Baumann D; Butler JE; Duman S; Hayes M; Carew-Jones F; Piguet O; Behnke S; Ridding MC; Berg D; Double KL, 2010, 'Substantia nigra echomorphology and motor cortex excitability', Neuroimage, vol. 50, pp. 1351 - 1356, http://dx.doi.org/10.1016/j.neuroimage.2010.01.088

Schofield E; Halliday GM; Kwok J; Loy C; Double KL; Hodges JR, 2010, 'Low serum progranulin predicts the presence of mutations: a prospective study', Journal of Alzheimer's Disease, vol. 22, pp. 981 - 984, http://dx.doi.org/10.3233/JAD-2010-101032

Double KL; Halliday GM; Dunkley PR; Dickson PW; Gerlach M; Riederer P, 2010, 'Pigmentation in the Human Brain and Risk of Parkinson's Disease', Annals of Neurology, vol. 67, pp. 553 - 553, http://dx.doi.org/10.1002/ana.21882

Double KL; Reyes S; Werry E; Halliday GM, 2010, 'Selective cell death in neurodegeneration: Why are some neurons spared in vulnerable regions?', Progress in Neurobiology, vol. 92, pp. 316 - 329, http://dx.doi.org/10.1016/j.pneurobio.2010.06.001

Kurz A; Double KL; Lastres-Becker I; Tozzi A; Tantucci M; Bockhart V; Bonin M; Garcia-Arencibia M; Nuber S; Schlaudraff F; Liss B; Fernandez-Ruiz J; Gerlach M; Wullner U; Luddens H; Calabresi P; Augurber G; Gispert S, 2010, 'A53T-alpha-synuclein overexpression impairs dopamine signalng and striatal synaptic plasticity in old mice', PLoS One, vol. 5, pp. e11464, http://dx.doi.org/10.1371/journal.pone.0011464

Double KL; Todd G; Duma SR, 2010, 'Pathophysiology of transcranial sonography signal changes in the human substantia nigra', International Review of Neurobiology, vol. 90, pp. 107 - 120, http://dx.doi.org/10.1016/S0074-7742(10)90008-1

Double KL; Rowe DB; Carew-Jones F; Hayes M; Chan DK; Blackie J; Corbett AJ; Joffe R; Fung VS; Morris JG; Riederer P; Gerlach M; Halliday GM, 2009, 'Anti-melanin antibodies are increased in sera in Parkinson`s disease', Experimental Neurology, vol. 217, pp. 297 - 301, http://dx.doi.org/10.1016/j.expneurol.2009.03.002

Piguet O; Double KL; Kril J; Harasty JA; Macdonald V; Mcritchie DA; Halliday GM, 2009, 'White matter loss in healthy ageing: A postmortem analysis', Neurobiology of Aging, vol. 30, pp. 1288 - 1295, http://dx.doi.org/10.1016/j.neurobiolaging.2007.10.015

Sutherland GR; Mellick GD; Newman J; Double KL; Stevens J; Lee L; Rowe DB; Silburn PA; Halliday GM, 2008, 'Haplotype analysis of the IGF2-INS-TH gene cluster in Parkinson`s disease', American Journal of Medical Genetics Part B - Neuropsychiatric Genetics, vol. 147B, pp. 495 - 499, http://dx.doi.org/10.1002/ajmg.b.30633

Gerlach M; Riederer P; Double KL, 2008, 'Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson`s disease', Parkinsonism and Related Disorders, vol. 14, pp. S185 - S188, http://dx.doi.org/10.1016/j.parkreldis.2008.04.028

Double KL; Dedov V; Fedorow HS; Kettle E; Halliday GM; Garner B; Brunk U, 2008, 'The comparative biology of neuromelanin and lipofuscin in the human brain', CMLS - Cellular and Molecular Life Sciences, vol. 65, pp. 1669 - 1682, http://dx.doi.org/10.1007/s00018-008-7581-9

Bohic S; Murphy KE; Paulus W; Cloetens P; Salome M; Susini J; Double KL, 2008, 'Intracellular Chemical Imaging of the Developmental Phases of Human Neuromelanin Using Synchrotron X-ray Microspectroscopy', Analytical Chemistry, vol. 80, pp. 9557 - 9566, http://dx.doi.org/10.1021/ac801817k

Dedov V; Griffiths F; Garner B; Halliday GM; Double KL, 2007, 'Lipid content determines aggregation of neuromelanin granules in vivo', Journal of Neural Transmission - Supplement, vol. 72, pp. 35 - 38, http://dx.doi.org/10.1007/978-3-211-73574-9-5

Behnke S; Double KL; Duma SR; Broe T; Guenther V; Becker GJ; Halliday GM, 2007, 'Substantia nigra echomorphology in the healthy very old: Correlation with motor slowing', Neuroimage, vol. 34, pp. 1054 - 1059, http://dx.doi.org/10.1016/j.neuroimage.2006.10.010

Tribl F; Riederer P; Double KL; Gerlach M, 2006, 'Neuromelanin, a pigment with unknown function', Neuroforum, vol. 12, pp. 190 - 196

Fedorow H; Halliday GM; Rickert CH; Gerlach M; Riederer P; Double KL, 2006, 'Evidence for specific phases in the development of human neuromelanin', Neurobiology of Aging, vol. 27, pp. 506 - 512, http://dx.doi.org/10.1016/j.neurobiolaging.2005.02.015

Tribl F; Riederer P; Double KL; Gerlach M, 2006, 'Neuromelanin, ein Pigment mit unbekannter Function', Neuroforum, vol. 2, pp. 188 - 194

Fedorow HS; Pickford R; Kettle E; Cartwright M; Halliday GM; Gerlach M; Riederer P; Garner B; Double KL, 2006, 'Investigation of the lipid component of neuromelanin', Journal of Neural Transmission, vol. 113, pp. 735 - 739, http://dx.doi.org/10.1007/s00702-006-0451-4

Halliday GM; Fedorow HS; Rickert C; Gerlach M; Riederer P; Double KL, 2006, 'Evidence for specific phases in the development of human neuromelanin', Journal of Neural Transmission, vol. 113, pp. 721 - 728, http://dx.doi.org/10.1007/s00702-006-0449-y

Double KL; Halliday GM, 2006, 'New face of neuromelanin', Journal of Neural Transmission, pp. 119 - 123

Double KL, 2006, 'Functional effects of neuromelanin and synthetic melanin in model systems', Journal of Neural Transmission, vol. 113, pp. 751 - 756, http://dx.doi.org/10.1007/s00702-006-0450-5

Youdim MB; Double KL; Gerlach M; Riederer P, 2006, 'Preface - Special Issue: Neuromelanin', Journal of Neural Transmission, vol. 113, pp. 717 - 719, http://dx.doi.org/10.1007/s00702-006-0520-8

Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow HS; Cartwright M; Griffiths F; Shepherd CE; Double KL, 2005, 'alpha-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson`s disease', Brain, vol. 128, pp. 2654 - 2664, http://dx.doi.org/10.1093/brain/awh584

Fedorow HS; Pickford R; Hook JM; Double KL; Halliday GM; Gerlach M; Riederer P; Garner B, 2005, 'Dolichol is the major lipid component of human substantia nigra neuromelanin', Journal of Neurochemistry, vol. 92, pp. 990 - 995, http://dx.doi.org/10.1111/j.1471-4159.2004.02975.x

Li J; Scheller C; Koutsilieri E; Griffiths F; Beart PM; Mercer L; Halliday GM; Kettle E; Rowe DB; Riederer P; Gerlach M; Rodriguez M; Double KL, 2005, 'Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells', Journal of Neurochemistry, vol. 95, pp. 599 - 608, http://dx.doi.org/10.1111/j.1471-4159.2005.03404.x

Fedorow HS; Tribl F; Halliday GM; Gerlach M; Riederer P; Double KL, 2005, 'Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson`s disease', Progress in Neurobiology, vol. 75, pp. 109 - 124, http://dx.doi.org/10.1016/j.pneurobio.2005.02.001

Gotz ME; Double KL; Gerlach M; Youdim MB; Riederer P, 2004, 'The relevance of iron in the pathogenesis of Parkinson`s disease', Annals of the New York Academy of Sciences, vol. 1012, pp. 193 - 208

Gerlach M; Double KL; Arzberger T; Leblhuber F; Tatschner T; Riederer P, 2003, 'Dopamine receptor agonists in current clinical use: Comparative dopamine receptor binding profiles defined in the human striatum', Journal of Neural Transmission, vol. 110, pp. 1119 - 1127

Gerlach M; Double KL; Reichmann H; Riederer P, 2003, 'Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinson`s disease', Journal of Neural Transmission, vol. 65, pp. 167 - 183

Foley PB; Gerlach M; Double KL; Riederer P, 2003, 'Dopamine receptor agonists in the therapy of Parkinson`s disease', Journal of Neural Transmission, vol. 111, pp. 1375 - 1446, http://dx.doi.org/10.1007/s00702-003-0059-x

Double KL; Rowe DB; Hayes M; Chan DK; Blackie J; Corbett AJ; Joffe R; Fung VS; Morris JG; Halliday GM, 2003, 'Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test', Archives of Neurology, vol. 60, pp. 545 - 549, http://dx.doi.org/10.1001/archneur.60.4.545

Halliday GM; Double KL; Macdonald V; Kril J, 2003, 'Identifying severely atrophic cortical subregions in Alzheimer's disease', Neurobiology of Aging, vol. 24, pp. 797 - 806, http://dx.doi.org/10.1016/S0197-4580(02)00227-0

Gerlach M; Double KL; Ben-Shachar D; Zecca L; Youdim MB; Riederer P, 2003, 'Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson`s disease', Neurotoxicity Research, vol. 5, pp. 35 - 44, http://dx.doi.org/10.1007/BF03033371

Double KL; Halliday GM; Henderson J; Griffiths F; Heinemann T; Riederer P; Gerlach M, 2003, 'The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration', Experimental Neurology, vol. 184, pp. 530 - 535, http://dx.doi.org/10.1016/j.expneurol.2003.08.006

Double KL; Gerlach M; Schunemann V; Trautwein AX; Zecca L; Gallorini M; Youdim MB; Riederer P; Ben-Shachar D, 2003, 'Iron-binding characteristics of neuromelanin of the human substantia nigra', Biochemical Pharmacology, vol. 66, pp. 489 - 494, http://dx.doi.org/10.1016/S0006-2952(03)00293-4

Berg D; Gerlach M; Youdim MBH; Double KL; Zecca L; Riederer P; Becker G, 2002, 'Erratum: Brain iron pathways and their relevance to Parkinson's disease (Journal of Neurochemistry (79) (225-236))', Journal of Neurochemistry, vol. 80, pp. 719, http://dx.doi.org/10.1046/j.0022-3042.2001.00742.x

Double KL; Ben-Shachar D; Youdim MB; Zecca L; Riederer P; Gerlach M, 2002, 'Influence of neuromelanin on oxidative pathways within the human substantia nigra', Neurotoxicology and Teratology, vol. 24, pp. 621 - 628, http://dx.doi.org/10.1016/S0892-0362(02)00218-0

Riederer P; Reichmann H; Janetzky B; Sian J; Lesch KP; Lange KW; Double KL; Nagatsu T; Gerlach M, 2001, 'Neural degeneration in Parkinson's disease.', Advances in neurology, vol. 86, pp. 125 - 136

Berg D; Gerlach M; Youdim MB; Double KL; Zecca L; Riederer P; Becker GJ, 2001, 'Brain iron pathways and their relevance to Parkinson`s disease.', Journal of Neurochemistry, vol. 79, pp. 225 - 236, http://dx.doi.org/10.1046/j.1471-4159.2001.00608.x

Gerlach M; Double KL; Youdim MB; Riederer P, 2000, 'Strategies for the protection of dopaminergic neurons against neurotoxicity', Neurotoxicity Research, vol. 2, pp. 99 - 114

Double KL; Zecca L; Costi P; Mauer M; Griesinger C; Ito S; Ben-Shachar D; Bringmann G; Fariello RG; Riederer P; Gerlach M, 2000, 'Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins', Journal of Neurochemistry, vol. 75, pp. 2583 - 2589, http://dx.doi.org/10.1046/j.1471-4159.2000.0752583.x

Double KL; Riederer P; Gerlach M, 1999, 'Significance of neuromelanin for neurodegeneration in Parkinson's disease', Drug News and Perspectives, vol. 12, pp. 333 - 340

Double KL; Riederer P; Gerlach M, 1999, 'The significance of neuromelanin for neurodegeneration in Parkinson`s disease', Drug News and Perspectives, vol. 1, pp. 8 - 12

Double KL; Riederer P; Gerlach M, 1999, 'The role of iron in 6-hydroxydopamine neurotoxicity', Advances in Neurology, vol. 80, pp. 287 - 296

Double KL; Maywald M; Schmittel M; Riederer P; Gerlach M, 1998, 'In vitro studies of ferritin iron release and neurotoxicity', Journal of Neurochemistry, vol. 70, pp. 2492 - 2499, http://dx.doi.org/10.1046/j.1471-4159.1998.70062492.x

Halliday GM; Mcritchie DA; Macdonald V; Double KL; Trent RJ; Mccusker E, 1998, 'Regional specifity of brain atrophy in Huntington`s Disease', Experimental Neurology, vol. 154, pp. 663 - 672, http://dx.doi.org/10.1006/exnr.1998.6919

Cullen KM; Halliday GM; Double KL; Brooks WS; Creasey H; Broe GA, 1997, 'Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease', Neuroscience, vol. 78, pp. 641 - 652, http://dx.doi.org/10.1016/S0306-4522(96)00569-6

Cullen K; Halliday GM; Double KL; Brooks WS; Creasey H; Broe T, 1997, 'Nucleus basalis cell loss is related to regional volumetric brain changes in Alzheimer's disease', Neuroscience, pp. 641 - 652

Harasty JA; Double KL; Halliday GM; Kril J; Mcritchie DA, 1997, 'Language associated cortical regions are proportionally larger in the female brain', Archives of Neurology, vol. 54, pp. 171 - 176, http://dx.doi.org/10.1001/archneur.1997.00550140045011

Double KL; Halliday GM; Mcritchie DA; Reid WG; Hely MA; Morris J, 1996, 'Regional brain atrophy in idiopathic Parkinson`s disease and diffuse Lewy body disease', Dementia, vol. 7, pp. 304 - 313, http://dx.doi.org/10.1159/000106896

Double KL; Halliday GM; Kril J; Harasty JA; Cullen K; Brooks WS; Creasey H; Broe T, 1996, 'Topography of brain atrophy during normal aging and Alzheimer's disease', Neurobiology of Aging, vol. 17, pp. 513 - 521, http://dx.doi.org/10.1016/0197-4580(96)00005-X

Lee CY; Double KL; Crocker AD, 1995, 'Expression of stereotyped behaviour requires stimulation of nigral D1 dopamine receptors', Brain Research, vol. 681, pp. 205 - 208, http://dx.doi.org/10.1016/0006-8993(95)00263-P

Double KL; Crocker AD, 1995, 'Dopamine receptors in the substantia nigra are involved in the regulation of muscle tone', Proceedings of the National Academy of Sciences of the United States of America, vol. 92, pp. 1669 - 1673, http://dx.doi.org/10.1073/pnas.92.5.1669

Double KL; Crocker AD, 1993, 'Quantitative electromyographic changes following modification of central dopaminergic transmission', Brain Research, vol. 604, pp. 342 - 344, http://dx.doi.org/10.1016/0006-8993(93)90388-4

Shiromani PJ; Overstreet DH; Lucero S; Double KL; Jeong DU, 1990, 'Dietary lithium blunts oxotremorine-induced hypothermia in a genetic animal model of depression', Lithium, vol. 1, pp. 186 - 189

Double KL; Crocker AD, 1990, 'Effects of inactivation of D1 dopamine receptors on stereotypic and thermic responses to quinpirole (LY 171555)', Neuroscience Letters, vol. 115, pp. 81 - 85, http://dx.doi.org/10.1016/0304-3940(90)90521-A

Double KL; Crocker AD, 1990, 'Effects of selective inactivation of D1 and D2 dopamine receptors on stereotypic and hypothermic responses to quinpirole (LY 171555)', European Journal of Pharmacology, vol. 183, pp. 1424 - 1425, http://dx.doi.org/10.1016/0014-2999(90)94557-E

Murphy KE; Double KL; Halliday GM, 2006, 'Differential expression of tyrosine hydroxylase isoforms in human substantia nigra', in Proceedings of Aust Neuroscience Society, 26th Annual meeting of the Australian Neuroscience Society, Sydney, pp. 51 - 51, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Jaeger P; Double KL, 2006, 'Neuromelanin, iron, and A-synuclein aggregation in Parkinson`s disease', in Proceedings of Aust Neuroscience Society, 26th Annual meeting of the Australian Neuroscience Society, Sydney, pp. 42 - 42, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Stevens J; Sutherland GR; Lee L; Double KL; Rowe DB; Halliday GM, 2005, 'Lack of association between a functional polymorphism in the tyrosine hydroxylase gene and Parkinson`s disease', in Journal of the Neurological Sciences, Elsevier Science BV, Amsterdam, Netherlands, pp. S158 - S158, presented at XVIIIth World Congress of Neurology, Sydney, 05 November 2005 - 11 November 2005

Li J; Double KL; Gerlach M; Riederer P; Gr nblatt E, 2005, 'The main effects of neuromelanin and synthetic dopamine melanin on oxidative stress related gene expression in cell lines', in Parkinsonism and Related Disorders, Elsevier Sci Ltd, Kidlington, Oxford, England, pp. 107 - 107, presented at 16th International Congress on Parkinson`s Disease and Related Disorders, Berlin, Germany, 05 June 2005 - 09 June 2005

Halliday GM; Fedorow HS; Rickert C; Gerlach M; Riederer P; Double KL, 2005, 'Evidence for specific phases in the development of human neuromelanin', in Parkinsonism and Related Disorders, Elsevier Sci Ltd, Kidlington, Oxford, England, pp. 58 - 58, presented at 16th International Congress on Parkinson`s Disease and Related Disorders, Berlin, Germany, 05 June 2005 - 09 June 2005

Fedorow HS; Pickford R; Hook J; Double KL; Halliday GM; Gerlach M; Riederer P; Garner B, 2005, 'Dolichol is the major lipid component of neuromelanin in human substanta nigra', in Parkinsonism and Related Disorders, Elsevier Sci Ltd, Kidlington, Oxford, England, pp. 107 - 107, presented at 16th International Congress on Parkinson`s Disease and Related Disorders, Berlin, Germany, 05 June 2005 - 09 June 2005

Fedorow HS; Garner B; Pickford R; Hook JM; Kettle E; Cartwright HR; Double KL; Gerlach M; Riederer P; Halliday GM, 2005, 'Investigations of the lipid component of neuromelanin', in Parkinsonism and Related Disorders, Elsevier Sci Ltd, Kidlington, Oxford, England, pp. 58 - 58, presented at 16th International Congress on Parkinson`s Disease and Related Disorders, Berlin, Germany, 05 June 2005 - 09 June 2005

Double KL; Li J; Scheller C; Koutsilieri E; Griffiths F; Beart PM; Mercer L; Halliday GM; Kettle E; Rowe DB; Riederer P; Gerlach M; Rodriguez M, 2005, 'Functional effects of neuromelanin and synthetic melanins in model systems', in Parkinsonism and Related Disorders, Elsevier Sci Ltd, Kidlington, Oxford, England, pp. 59 - 59, presented at 16th International Congress on Parkinson`s Disease and Related Disorders, Berlin, Germany, 05 June 2005 - 09 June 2005

Double KL; Halliday GM, 2005, 'New face of melanin', in Parkinsonism and Related Disorders, Elsevier Sci Ltd, Kidlington, Oxford, England, pp. 65 - 65, presented at 16th International Congress on Parkinson`s Disease and Related Disorders, Berlin, Germany, 05 June 2005 - 09 June 2005

Fedorow HS; Pickford R; Hook JM; Double KL; Halliday GM; Gerlach M; Riederer P; Garner B, 2005, 'Identification of the major lipid component of neuromelanin in human dopamine neurons', in Proceedings of Aust Neuroscience Society, 25th Annual Meeting of the Australian Neuroscience Society, Perth, WA, pp. 139 - 139, presented at 25th Annual Meeting of the Australian Neuroscience Society, Perth, WA, 30 January 2005 - 02 February 2005

Griffiths F; Mercer L; Beart PM; Halliday GM; Riederer P; Gerlach M; Double KL, 2005, 'Morphological effects of neuromelanin and dopamine melanin on primary cell cultures', in Proceedings of Aust Neuroscience Society, 25th Annual Meeting of the Australian Neuroscience Society, Perth, WA, pp. 139 - 139, presented at 25th Annual Meeting of the Australian Neuroscience Society, Perth, WA, 30 January 2005 - 02 February 2005

Double KL; Li J; Scheller C; Koutsilieri E; Griffiths F; Beart PM; Mercer L; Halliday GM; Kettle E; Rowe DB; Riederer P; Gerlach M; Rodriguez M, 2005, 'Functional effects of neuromelanin on neuronal and glial cells in vitro', in Proceedings of Aust Neuroscience Society, 25th Annual Meeting of the Australian Neuroscience Society, Perth, WA, pp. 38 - 38, presented at 25th Annual Meeting of the Australian Neuroscience Society, Perth, WA, 30 January 2005 - 02 February 2005

Gerlach M; Double KL; Youdim MB; Riederer P, 2005, 'Potential sources of increased iron in the substantia nigra of parkinsonian patients', in 16th International Congress of Parkinson`s Disease and Related disorders, Berlin, Germany, pp. 133 - 142, presented at 16th International Congress of Parkinson`s Disease and Related disorders, Berlin, Germany

Potts HS; Halliday GM; Cartwright M; Rickert C; Gerlach M; Riederer P; Double KL, 2004, 'The development of nigral neuromelanin in human dopamine neurons', in Proceedings of Aust Neuroscience Society, 24th Annual Meeting of the Australian Neuroscience Society, Melbourne Convention Centre, pp. 150 - 150, presented at 24th Annual Meeting of the Australian Neuroscience Society, Melbourne Convention Centre, 27 January 2004 - 30 January 2004

Double KL; Gerlach M; Schunemann V; Trautwein AX; Zecca L; Gallorini M; Youdim MB; Riederer P; Ben-Shachar D, 2003, 'Iron binding characteristics of neuromelanin of the human substantia nigra', in Proceedings of Aust Neuroscience Society, 23rd Annual Meeting of the Australian Neuroscience Society, Adelaide, Sth Aust, pp. 904 - 0904, presented at 23rd Annual Meeting of the Australian Neuroscience Society, Adelaide, Sth Aust, 28 January 2003 - 31 January 2003

Double KL; Halliday GM; Henderson JM; Griffiths F, 2003, 'The dopamine induced receptor lisuride attenuates iron-mediated dopaminergic neurodegeneration', in Proceedings of Aust Neuroscience Society, 23rd Annual Meeting of the Australian Neuroscience Society, Adelaide, Sth Aust, pp. 371 - 371, presented at 23rd Annual Meeting of the Australian Neuroscience Society, Adelaide, Sth Aust, 28 January 2003 - 31 January 2003

Ophof A; Double KL; Cartwright M; Halliday GM, 2003, 'Density of neuromelanin-pigment and pigment-associated alpha-synuclein in Parkinson`s disease', in Proceedings of Aust Neuroscience Society, 23rd Annual Meeting of the Australian Neuroscience Society, Adelaide, Sth Aust, pp. 370 - 370, presented at 23rd Annual Meeting of the Australian Neuroscience Society, Adelaide, Sth Aust, 28 January 2003 - 31 January 2003

Fedorow HS; Double KL; Kettle E; Cartwright M; Griffiths F; Halliday GM, 2003, 'Neuromelanin in the substantia nigra has a significant lipid component', in Proceedings of Aust Neuroscience Society, 23rd Annual Meeting of the Australian Neuroscience Society, Adelaide, Sth Aust, pp. 381 - 381, presented at 23rd Annual Meeting of the Australian Neuroscience Society, Adelaide, Sth Aust, 28 January 2003 - 31 January 2003

Double KL; Halliday GM; Henderson JM; Griffiths F; Heinemann T; Riederer P; Gerlach M, 2002, 'The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration', in Australian Health and Medical Research Congress, Australian Health and Medical Research Congress 2002, Melbourne Convention Centre, pp. 2649 - 2649, presented at Australian Health and Medical Research Congress 2002, Melbourne Convention Centre, 24 November 2002 - 29 November 2002

Double KL; Rowe DB; Halliday GM; Riederer P; Gerlach M, 2002, 'A biochemical marker for central dopaminergic cell loss', in Movement Disorders, Wiley-Liss, Hoboken, NJ, USA, pp. 67 - 67, presented at 7th International Congress of Parkinson`s Disease and Movement Disorders Society Annual General Meeting, Miami, Florida, USA, 10 November 2002 - 14 November 2002

Double KL; Halliday GM; Rowe DB; Henderson JM; Riederer P; Gerlach M, 2002, 'The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration', in Movement Disorders, Wiley-Liss, Hoboken, NJ, USA, pp. 50 - 50, presented at 7th International Congress of Parkinson`s Disease and Movement Disorders Society Annual General Meeting, Miami, Florida, USA, 10 November 2002 - 14 November 2002

Griffiths F; Double KL; Rowe DB, 2002, 'The effect of human and synthetic neuromelanin on neuronal and glial cell lines', in Proceedings of Aust Neuroscience Society, 22nd Annual meeting of the Australian Neuroscience Society, Darling Harbour, Sydney, pp. 133 - 133, presented at 22nd Annual meeting of the Australian Neuroscience Society, Darling Harbour, Sydney, 04 February 2002 - 06 February 2002

Double KL; Rowe DB; Halliday GM, 2002, 'Diagnosing preclinical Parkinson`s disease: The Sydney DEDCEL study', in Proceedings of Aust Neuroscience Society, 22nd Annual meeting of the Australian Neuroscience Society, Darling Harbour, Sydney, pp. 132 - 132, presented at 22nd Annual meeting of the Australian Neuroscience Society, Darling Harbour, Sydney, 04 February 2002 - 06 February 2002

Double KL; Rowe DB; Griffiths F; Chan DK; Riederer P; Gerlach M, 2001, 'A specific immune response in Parkinson`s disease indicates central dopaminergic cell death.', in Proceedings of Aust Neuroscience Society, 21st Annual Meeting of the Australian Neuroscience Society, Brisbane, Qld, pp. 125 - 125, presented at 21st Annual Meeting of the Australian Neuroscience Society, Brisbane, Qld, 28 January 2001 - 31 January 2001

Macdonald V; Halliday GM; Mcritchie DA; Double KL; Mccusker E, 1998, 'Brain atrophy in Huntington`s disease', in Pilowsky P (ed.), 18th Annual Meeting of the Australian Neuroscience Society, 18th Annual meeting Australian Neuroscience Society, Canberra, pp. 203, presented at 18th Annual meeting Australian Neuroscience Society, Canberra, 27 January 1998 - 30 January 1998

Double KL; Halliday GM; Kril J, 1997, 'Temporal and frontal lobe atrophy characterises Alzheimer's disease', in Brain Pathology, Int Society Neuropathology, Los Angeles, CA, USA, pp. 1201 - 1201, presented at XIIIth International Congress of Neuropathology, Perth, WA, 07 September 1997 - 12 September 1997

Kril J; Halliday GM; Double KL; Harding AJ, 1997, 'Patterns of neuropathology in Alzheimer's disease and ageing', in Satellite Meeting of the 16th Congress of the International Association of Gerontology, Satellite Meeting of the 16th Congress of the International Association of Gerontology, Honolulu, Hawaii, pp. 48 - 49, presented at Satellite Meeting of the 16th Congress of the International Association of Gerontology, Honolulu, Hawaii, 16 August 1997 - 18 August 1997

Double KL; Halliday GM; Kril J, 1997, 'Temporal and frontal lobe atrophy characterises Alzheimer's disease', in Journal of Clinical Neuroscience, Churchill Livingstone, Edinburgh, Midlothian, Scotland, pp. 393 - 394, presented at Australian Association of Neurologists Annual Scientific Meeting 1997, Sydney, 30 April 1997 - 02 May 1997

Double KL, 2008, 'Brain cell death in Parkinson`s disease', in Brain cell death in Parkinson`s disease, Parkinson's Australia National Conference, Sydney, presented at Parkinson's Australia National Conference, Sydney, 16 October 2008 - 17 October 2008

Ng KY; Hayes M; Mercer S; Garner B; Halliday GM; Carew-Jones F; Double KL, 2008, 'Cholesterol in Parkinson`s disease', in Cholesterol in Parkinson`s disease, Parkinson's Australia National Conference, Sydney, presented at Parkinson's Australia National Conference, Sydney, 16 October 2008 - 17 October 2008